Aromatic clusters in protein–protein and protein–drug complexes

Aromatic rings are important residues for biological interactions and appear to a large extent as part of protein–drug and protein–protein interactions. They are relevant for both protein stability and molecular recognition processes due to their natural occurrence in aromatic aminoacids (Trp, Phe, Tyr and His) as well as in designed drugs since they are believed to contribute to optimizing both affinity and specificity of drug-like molecules. Despite the mentioned relevance, the impact of aromatic clusters on protein–protein and protein–drug complexes is still poorly characterized, especially in those that go beyond a dimer. In this work, we studied protein–drug and protein–protein complexes and systematically analyzed the presence and structure of their aromatic clusters. Our results show that aromatic clusters are highly prevalent in both protein–protein and protein–drug complexes, and suggest that protein–protein aromatic clusters have idealized interactions, probably because they were optimized by evolution, as compared to protein–drug clusters that were manually designed. Interestingly, the configuration, solvent accessibility and secondary structure of aromatic residues in protein–drug complexes shed light on the relation between these properties and compound affinity, allowing researchers to better design new molecules.

[1]  Christopher W Murray,et al.  Experiences in fragment-based drug discovery. , 2012, Trends in pharmacological sciences.

[2]  P. Tufféry,et al.  Interfering peptides targeting protein-protein interactions: the next generation of drugs? , 2017, Drug discovery today.

[3]  L. Gierasch,et al.  The Role of Aromatic-Aromatic Interactions in Strand-Strand Stabilization of β-Sheets. , 2013, Journal of molecular biology.

[4]  A. Bogan,et al.  Anatomy of hot spots in protein interfaces. , 1998, Journal of molecular biology.

[5]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[6]  C. Chothia,et al.  The atomic structure of protein-protein recognition sites. , 1999, Journal of molecular biology.

[7]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[8]  S. Karlin,et al.  Geometry of interplanar residue contacts in protein structures. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[10]  T. Ritchie,et al.  Physicochemical descriptors of aromatic character and their use in drug discovery. , 2014, Journal of medicinal chemistry.

[11]  Simone Marsili,et al.  Thermodynamics of stacking interactions in proteins. , 2008, Physical chemistry chemical physics : PCCP.

[12]  Stephen D Pickett,et al.  The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. , 2011, Drug discovery today.

[13]  S. Vajda,et al.  Anchor residues in protein-protein interactions. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. David Sherrill,et al.  Beyond the benzene dimer : An investigation of the additivity of π-π interactions , 2005 .

[15]  R. Nussinov,et al.  Protein–protein interactions: Structurally conserved residues distinguish between binding sites and exposed protein surfaces , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  F. Gervasio,et al.  Stacking and T-shape competition in aromatic-aromatic amino acid interactions. , 2002, Journal of the American Chemical Society.

[17]  M. Schapira,et al.  A systematic analysis of atomic protein–ligand interactions in the PDB , 2017, MedChemComm.

[18]  David C Fry,et al.  Targeting protein-protein interactions for drug discovery. , 2015, Methods in molecular biology.

[19]  Giovanna Zinzalla,et al.  Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. , 2009, Future medicinal chemistry.

[20]  Xiaomin Luo,et al.  Non-covalent interactions with aromatic rings: current understanding and implications for rational drug design. , 2013, Current pharmaceutical design.

[21]  F. Diederich,et al.  Aromatic Rings in Chemical and Biological Recognition: Energetics and Structures , 2011 .

[22]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[23]  G. McGaughey,et al.  pi-Stacking interactions. Alive and well in proteins. , 1998, The Journal of biological chemistry.

[24]  Esteban Lanzarotti,et al.  Aromatic-Aromatic Interactions in Proteins: Beyond the Dimer , 2011, J. Chem. Inf. Model..

[25]  E. Birney,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[26]  D. Scott,et al.  Small molecules, big targets: drug discovery faces the protein–protein interaction challenge , 2016, Nature Reviews Drug Discovery.

[27]  Richard D. Taylor,et al.  Rings in drugs. , 2014, Journal of medicinal chemistry.

[28]  J. Fernández-Recio,et al.  Hot-spot analysis for drug discovery targeting protein-protein interactions , 2018, Expert opinion on drug discovery.

[29]  Adam Godzik,et al.  Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences , 2006, Bioinform..

[30]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[31]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[32]  W. Delano Unraveling hot spots in binding interfaces: progress and challenges. , 2002, Current opinion in structural biology.

[33]  L. Holm,et al.  The Pfam protein families database , 2005, Nucleic Acids Res..

[34]  M. Schapira,et al.  A Systematic Analysis of Atomic Protein-Ligand Interactions in the PDB , 2017, bioRxiv.

[35]  Jason E. Gestwicki,et al.  Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity , 2012, Expert Reviews in Molecular Medicine.